The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury

References

• Mohebi R, Karimi Galougahi K, Garcia JJ, et al. Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: an ADAPT-DES Substudy. JACC: Cardiovasc Interv. 2022;15(7):753–766. doi:10.1016/j.jcin.2021.11.026
   PubMed Web of Science ®Google Scholar
• Gruberg L, Mintz GS, Mehran R, et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol. 2000;36(5):1542–1548. doi:10.1016/S0735-1097(00)00917-7
   PubMed Web of Science ®Google Scholar
• Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105(19):2259–2264. doi:10.1161/01.CIR.0000016043.87291.33
   PubMed Web of Science ®Google Scholar
• Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(2):e21–e129. doi:10.1016/j.jacc.2021.09.006
   PubMed Web of Science ®Google Scholar
• Davenport MS, Perazella MA, Yee J, et al. Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294(3):660–668. doi:10.1148/radiol.2019192094
   PubMed Web of Science ®Google Scholar
• Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393–1399. doi:10.1016/j.jacc.2004.06.068
   PubMed Web of Science ®Google Scholar
• Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015;313(8):837–846. doi:10.1001/jama.2015.0602
   PubMed Web of Science ®Google Scholar
• Fan L, Inker LA, Rossert J, et al. Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test. Nephrol Dial Transplant. 2014;29(6):1195–1203. doi:10.1093/ndt/gft509
   PubMed Web of Science ®Google Scholar
• Droppa M, Desch S, Blase P, et al. Impact of N-acetylcysteine on contrast-induced nephropathy defined by cystatin C in patients with ST-elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol. 2011;100(11):1037–1043. doi:10.1007/s00392-011-0338-8
   PubMed Web of Science ®Google Scholar
• Potok OA, Ix JH, Shlipak MG, et al. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: a Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT). Am J Kidney Dis. 2020;76(6):765–774. doi:10.1053/j.ajkd.2020.05.017
   PubMed Web of Science ®Google Scholar
• Chen DC, Shlipak MG, Scherzer R, et al. Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure. Am J Kidney Dis. 2022;80(6):762–772.e1. doi:10.1053/j.ajkd.2022.05.011
   PubMed Web of Science ®Google Scholar
• Chen DC, Shlipak MG, Scherzer R, et al. Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality. JAMA Network Open. 2022;5(2):e2148940. doi:10.1001/jamanetworkopen.2021.48940
   PubMed Web of Science ®Google Scholar
• Pinsino A, Fabbri M, Braghieri L, et al. The difference between cystatin C- and creatinine-based assessment of kidney function in acute heart failure. ESC Heart Fail. 2022;9(5):3139–3148. doi:10.1002/ehf2.13975
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29. doi:10.1056/NEJMoa1114248
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Mehran R, Owen R, Chiarito M, et al. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet. 2021;398(10315):1974–1983. doi:10.1016/S0140-6736(21)02326-6
   PubMed Web of Science ®Google Scholar
• Hsu CY, Yang W, Parikh RV, et al. Race, Genetic Ancestry, and Estimating Kidney Function in CKD. N Engl J Med. 2021;385(19):1750–1760. doi:10.1056/NEJMoa2103753
   PubMed Web of Science ®Google Scholar
• Delgado C, Baweja M, Crews DC, et al. A Unifying Approach for GFR Estimation: recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease. Am J Kidney Dis. 2022;79(2):268–288.e1. doi:10.1053/j.ajkd.2021.08.003
   PubMed Web of Science ®Google Scholar
• Lin YL, Chang IC, Liou HH, et al. Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease. Sci Rep. 2021;11(1):16863. doi:10.1038/s41598-021-96447-9
   PubMed Web of Science ®Google Scholar
• Duan SB, Liu GL, Yu ZQ, Pan P. Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients. Clin Nephrol. 2013;80(5):349–354. doi:10.5414/CN107829
   PubMed Web of Science ®Google Scholar
• Andreucci M, Faga T, Riccio E, Sabbatini M, Pisani A, Michael A. The potential use of biomarkers in predicting contrast-induced acute kidney injury. Int J Nephrol Renovasc Dis. 2016;9:205–221. doi:10.2147/IJNRD.S105124
   PubMed Web of Science ®Google Scholar
• Ribichini F, Gambaro G, Graziani MS, et al. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem. 2012;58(2):458–464. doi:10.1373/clinchem.2011.170464
   PubMed Web of Science ®Google Scholar
• Liu YH, Xue JH, Wu DX, et al. A novel simple experimental model for low-osmolar contrast-induced acute kidney injury using different definitions based on the levels of serum creatinine and cystatin C. BMC Nephrol. 2019;20(1):243. doi:10.1186/s12882-019-1436-5
   PubMedGoogle Scholar
• Nishiguchi S, Yamada M, Fukutani N, et al. Differential association of frailty with cognitive decline and sarcopenia in community-dwelling older adults. J Am Med Dir Assoc. 2015;16(2):120–124. doi:10.1016/j.jamda.2014.07.010
   PubMed Web of Science ®Google Scholar
• Wang S, Xie L, Xu J, et al. Predictive value of serum creatinine/cystatin C in neurocritically ill patients. Brain Behav. 2019;9(12):e01462. doi:10.1002/brb3.1462
   PubMed Web of Science ®Google Scholar
• Jiesisibieke ZL, Tung TH, Xu QY, et al. Association of acute kidney injury with frailty in elderly population: a systematic review and meta-analysis. Ren Fail. 2019;41(1):1021–1027. doi:10.1080/0886022X.2019.1679644
   PubMed Web of Science ®Google Scholar
• Almén MS, Björk J, Nyman U, et al. Shrunken Pore Syndrome Is Associated With Increased Levels of Atherosclerosis-Promoting Proteins. Kidney Int Rep. 2019;4(1):67–79. doi:10.1016/j.ekir.2018.09.002
   PubMed Web of Science ®Google Scholar
• Grubb A. Shrunken pore syndrome - a common kidney disorder with high mortality. Diagnosis, prevalence, pathophysiology and treatment options. Clin Biochem. 2020;83:12–20. doi:10.1016/j.clinbiochem.2020.06.002
   PubMed Web of Science ®Google Scholar
• Zhang LW, Luo MQ, Xie XW, et al. Shrunken Pore Syndrome: a New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury. J Am Heart Assoc. 2023;12(1):e027980. doi:10.1161/JAHA.122.027980
   PubMed Web of Science ®Google Scholar
• Xhakollari L, Jujic A, Molvin J, et al. Proteins linked to atherosclerosis and cell proliferation are associated with the shrunken pore syndrome in heart failure patients: shrunken pore syndrome and proteomic associations. Proteomics Clin Appl. 2021;15(4):e2000089. doi:10.1002/prca.202000089
   PubMed Web of Science ®Google Scholar
• Öberg CM, Lindström M, Grubb A, Christensson A. Potential relationship between eGFR(cystatin C) /eGFR(creatinine) -ratio and glomerular basement membrane thickness in diabetic kidney disease. Physiol Rep. 2021;9(13):e14939. doi:10.14814/phy2.14939
   PubMed Web of Science ®Google Scholar
• Wu Z, Wang L, Li Y, Yao Y, Zeng R. Shrunken Pore Syndrome Is Associated with Renal Function Decline in Female Patients with Kidney Diseases. Biomed Res Int. 2022;2022:2177991. doi:10.1155/2022/2177991
   PubMed Web of Science ®Google Scholar
• Frydman S, Freund O, Banai A, Zornitzki L, Banai S, Shacham Y. Relation of Gender to the Occurrence of AKI in STEMI Patients. J Clin Med. 2022;11(21):6565. doi:10.3390/jcm11216565
   PubMed Web of Science ®Google Scholar
• Khoury S, Frydman S, Abu-Katash H, et al. Impact of care bundles on the occurrence and outcomes of acute kidney injury among patients with ST-segment elevation myocardial infarction. J Nephrol. 2023;36(9):2491–2497. doi:10.1007/s40620-023-01652-6
   PubMed Web of Science ®Google Scholar